Utilidad del proto-oncogen ret en el diagnóstico del carcinoma medular de tiroides de tipo hereditario. correlación con los hallazgos quirúrgicos

Hundahl, 1998, A National Cancer Data Base Report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995, Cancer, 83, 2638, 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 Carreño, 1997, Cáncer de tiroides. Aspectos epidemiológicos, diagnósticos y terapeúticos, Acta Otorrinolaringol Esp, 48, 647 Hazard, 1959, Medullary (solid) thyroid carcinoma of the thyroid; a clinicopathologic entity, J Clin Endocrinol Metab, 19, 152, 10.1210/jcem-19-1-152 Chi, 1994, Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET protooncogene, Surgery, 116, 124 Eng, 1996, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis, JAMA, 276, 1575, 10.1001/jama.1996.03540190047028 Mathew, 1987, A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10, Nature, 328, 527, 10.1038/328527a0 Simpson, 1987, Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage, Nature, 328, 528, 10.1038/328528a0 Mulligan, 1993, Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A, Nature, 363, 458, 10.1038/363458a0 Santoro, 1995, Germ-line mutations of MEN 2A and MEN 2B activate RET as a dominant transforming gene by different molecular mechanisms, Science, 267, 381, 10.1126/science.7824936 Landsvater, 1996, Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers, Cancer Res, 56, 4853 Melvin, 1971, Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay, N Engl J Med, 285, 1115, 10.1056/NEJM197111112852004 Wells, 1978, Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging, Ann Surg, 188, 377, 10.1097/00000658-197809000-00013 Lips, 1994, Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A, N Engl J Med, 331, 828, 10.1056/NEJM199409293311302 Oriola, 1996, Genetic analysis of seven Mediterranean families with multiple endocrine neoplasia type 2A, Clin Endocrinol, 44, 207, 10.1046/j.1365-2265.1996.652473.x Biarnés, 1996, Alteraciones moleculares del protooncogen RET en familias con neoplasia endocrina múltiple tipo 2A, Med Clin (Barc, 107, 321 Matias-Guiu, 1998, RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II, Adv Anat Pathol, 5, 196, 10.1097/00125480-199805000-00058 Pomares-Gómez, 1999, Análisis genético de las mutaciones de RET en las familias con neoplasia endocrina múltiple tipo 2 de la Comunidad de Murcia, Med Clin (Barc, 112, 646 Gavilán, 1996, Carcinoma medular de tiroides. Factores pronósticos, Rev Clin Esp, 196, 92 Bergholm, 1997, Long term follow-up of patients with medullary carcinoma of the thyroid, Cancer, 79, 132, 10.1002/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5 Modigliani, 1998, Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients, Clin Endocrinol, 48, 265, 10.1046/j.1365-2265.1998.00392.x Bergholm, 1989, Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981, Cancer, 63, 1196, 10.1002/1097-0142(19890315)63:6<1196::AID-CNCR2820630626>3.0.CO;2-O Duh, 1989, Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy, Arch Surg, 124, 1206, 10.1001/archsurg.1989.01410100112019 Pacini, 1995, Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret mutations, Surgery, 118, 1031, 10.1016/S0039-6060(05)80110-2 Niccoli, 1997, and The French Medullary Study Group. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients, J Clin Endocrinol Metab, 82, 338, 10.1210/jc.82.2.338 Perry, 1996, Physiologic versus neoplastic C-cell hyperplasia of the thyroid, Cancer, 77, 750, 10.1002/(SICI)1097-0142(19960215)77:4<750::AID-CNCR22>3.0.CO;2-Z 1997, International Union Against Cancer. TNM classification of malignant tumours, 5th edition Cushman, 1962, Familial endocrine tumors: report of two unrelated kindreds affected with pheochromocytomas, one also with multiple thyroid carcinomas, Am J Med, 32, 352, 10.1016/0002-9343(62)90126-2 Wohlk, 1996, Application of genetic screening information to management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2, Endocrinol Metab Clin North Am, 25, 1, 10.1016/S0889-8529(05)70310-8 Evans, 1999, The surgical treatment of medullary thyroid carcinoma, Semin Surg Oncol, 16, 50, 10.1002/(SICI)1098-2388(199901/02)16:1<50::AID-SSU9>3.0.CO;2-6 Van Heyningen, 1994, Genetics. One gene-four syndromes, Nature, 367, 319, 10.1038/367319a0 Decker, 1995, Progress in genetic screening of multiple endocrine neoplasia type 2A: is calcitonin testing obsolete?, Surgery, 118, 257, 10.1016/S0039-6060(05)80332-0 Simpson, 1990, Results of a screening program for C-cell disease (medullary thyroid cancer and C-cell hyperplasia, Cancer, 65, 1570, 10.1002/1097-0142(19900401)65:7<1570::AID-CNCR2820650720>3.0.CO;2-0 Ponder, 1988, Screening for disease. Risk estimation and screening in families of patients with medullary thyroid carcinoma, Lancet, 1, 397, 10.1016/S0140-6736(88)91191-9 Iler, 1999, Multiple endocrine neoplasia type 2A: a 25-year review, J Pediatr Surg, 34, 92, 10.1016/S0022-3468(99)90236-1 Gharib, 1992, Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970, Mayo Clin Proc, 67, 934, 10.1016/S0025-6196(12)60923-9 Gimm, 1997, Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?, Surgery, 122, 1124, 10.1016/S0039-6060(97)90217-8 Telander, 1989, Medullary carcinoma in children. Results on early detection and surgery, Arch Surg, 124, 841, 10.1001/archsurg.1989.01410070099020 Mathew, 1991, and the MEN 2A International Collaborative Group. Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers, Lancet, 337, 7, 10.1016/0140-6736(91)93329-8 1988, National groups for the study of MEN 2 syndromes. Genetic markers in multiple endocrine neoplasia type 2 (editorial, Lancet, 1, 396